Glycos Biotechnologies Inc. is moving closer to worldwide commercialization of its microbial technology.

The Houston biochemical company said it successfully produced lactic acid and advanced ethanol in a commercial size facility capable of producing up to 150,000 liters of chemicals.

“Replicating what has been accomplished in our lab now in a commercial setting, and at a larger scale, is a significant achievement for GlycosBio,” said Rich Cilento, Glycos chief executive officer. “With the pilot plant successfully operational we are now focused on engaging the marketplace to secure additional commercialization partnerships around the world.”

The company’s technology involves consuming carbon from multiple non-sugar feedstock sources to produce a variety of chemical products.